Vaxil Bio Ltd.
VXLLD
$0.10
-$0.0757-43.09%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 280.40K | 311.40K | 396.00K | 430.40K | 679.40K |
Total Receivables | 195.50K | 189.70K | 211.00K | 200.20K | 9.60K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | 8.30K | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 475.90K | 509.40K | 607.00K | 630.50K | 689.00K |
|
|||||
Total Current Assets | 475.90K | 509.40K | 607.00K | 630.50K | 689.00K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 475.90K | 509.40K | 607.00K | 630.50K | 689.00K |
|
|||||
Total Accounts Payable | 24.40K | 8.30K | 60.70K | 50.40K | 67.20K |
Total Accrued Expenses | 3.50K | 3.50K | -- | 5.10K | 5.20K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 27.80K | 11.80K | 60.70K | 55.50K | 72.40K |
|
|||||
Total Current Liabilities | 27.80K | 11.80K | 60.70K | 55.50K | 72.40K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 27.80K | 11.80K | 60.70K | 55.50K | 72.40K |
|
|||||
Common Stock & APIC | 11.18M | 11.17M | 11.90M | 11.74M | 11.87M |
Retained Earnings | -13.64M | -13.58M | -14.44M | -14.22M | -14.34M |
Treasury Stock & Other | 2.90M | 2.90M | 3.09M | 3.05M | 3.08M |
Total Common Equity | 448.00K | 497.60K | 546.30K | 575.00K | 616.60K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 448.00K | 497.60K | 546.30K | 575.00K | 616.60K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 448.00K | 497.60K | 546.30K | 575.00K | 616.60K |
|